New York, NY -- (ReleaseWire) -- 02/07/2013 --Cannabis Science, Inc. (OTCQB: CBIS) has been heavily investing in the research and development of cannabis, otherwise known as marijuana. With focus on utilizing the medicinal use of marijuana, Cannabis Science is looking to bring medical treatments to areas such as cancer, PTSD and HIV. If CBIS achieves its goals, detractors may soon become supporters.
Debates on the use of marijuana have been growing despite its legalization in 18 states for medicinal purposes and 2 states for recreational use. Further driving the point home, Colorado recently granted recreational use of marijuana to its residents, a perfect fit for Cannabis Science's current base of operations.
Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products.
Get everything investors are looking for when trading CBIS by getting the free full report here: http://www.monstertradingalerts.com/market-scan/?symbol=CBIS
Organovo Holdings, Inc. (OTCQX :ONVO) announced its intention to redeem two classes of outstanding warrants initially issued to investors participating in private placement financings in 2011 and 2012.
The warrant redemption will raise non-dilutive capital, enable Organovo to significantly improve its balance sheet, help position the Company to qualify to list its common stock on the NYSE MKT or NASDAQ exchange, and decrease a significant portion of the derivative liability from its balance sheet.
Previously, on December 21, 2012, the Company completed a tender offer including the same warrants. At that time, approximately two-thirds of warrant holders elected to participate in the tender offer and exercised their warrants at $0.80 per share.
Organovo designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications.
Find out more on ONVO here:
MonsterTradingAlerts.com issues momentum alerts on stocks that can provide gains to day traders. MonsterTradingAlerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. MonsterTradingAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals MonsterTradingAlerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the MonsterTradingAlerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.MonsterTradingAlerts.com
Disclosure: MonsterTradingAlerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit MonsterTradingAlerts.com website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
Alexander K. Neumann
Monster Trading Alerts